Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 161 entries
Sorted by: Best Match Show Resources per page
Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study.

Journal of cardiovascular and thoracic research

Kelishadi R, Heshmat R, Farzadfar F, Esmaeil Motlag M, Bahreynian M, Safiri S, Ardalan G, Rezaei Darzi E, Asayesh H, Rezaei F, Qorbani M.
PMID: 28451083
J Cardiovasc Thorac Res. 2017;9(1):12-20. doi: 10.15171/jcvtr.2017.02. Epub 2017 Mar 13.

No abstract available.

Cite
Kelishadi R, Heshmat R, Farzadfar F, et al. Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study. J Cardiovasc Thorac Res. 2017;9(1):12-20doi: 10.15171/jcvtr.2017.02.
Kelishadi, R., Heshmat, R., Farzadfar, F., Esmaeil Motlag, M., Bahreynian, M., Safiri, S., Ardalan, G., Rezaei Darzi, E., Asayesh, H., Rezaei, F., & Qorbani, M. (2017). Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study. Journal of cardiovascular and thoracic research, 9(1), 12-20. https://doi.org/10.15171/jcvtr.2017.02
Kelishadi, Roya, et al. "Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study." Journal of cardiovascular and thoracic research vol. 9,1 (2017): 12-20. doi: https://doi.org/10.15171/jcvtr.2017.02
Kelishadi R, Heshmat R, Farzadfar F, Esmaeil Motlag M, Bahreynian M, Safiri S, Ardalan G, Rezaei Darzi E, Asayesh H, Rezaei F, Qorbani M. Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study. J Cardiovasc Thorac Res. 2017;9(1):12-20. doi: 10.15171/jcvtr.2017.02. Epub 2017 Mar 13. PMID: 28451083; PMCID: PMC5402022.
Copy Download .nbib Format: NLM
Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis.

Journal of research in pharmacy practice

Varmaghani M, Meshkini AH, Farzadfar F, Yousefi M, Yaghoubifard S, Varahrami V, Darzi ER, Anabi M, Kebriaeezadeh A, Zekri HS.
PMID: 25984541
J Res Pharm Pract. 2015 Apr-Jun;4(2):51-6. doi: 10.4103/2279-042X.155750.

OBJECTIVE: In this study, we aimed to assess comparative productivity of 21 pharmaceutical companies in Iran during 2000-2013.METHODS: To evaluate the productivity trend of pharmaceutical companies in Iran, we used data envelopment analysis-based Malmquist index. "Total assets" and "capital...

Cite
Varmaghani M, Meshkini AH, Farzadfar F, et al. Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis. J Res Pharm Pract. 2015;4(2):51-6doi: 10.4103/2279-042X.155750.
Varmaghani, M., Meshkini, A. H., Farzadfar, F., Yousefi, M., Yaghoubifard, S., Varahrami, V., Darzi, E. R., Anabi, M., Kebriaeezadeh, A., & Zekri, H. S. (2015). Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis. Journal of research in pharmacy practice, 4(2), 51-6. https://doi.org/10.4103/2279-042X.155750
Varmaghani, Mehdi, et al. "Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis." Journal of research in pharmacy practice vol. 4,2 (2015): 51-6. doi: https://doi.org/10.4103/2279-042X.155750
Varmaghani M, Meshkini AH, Farzadfar F, Yousefi M, Yaghoubifard S, Varahrami V, Darzi ER, Anabi M, Kebriaeezadeh A, Zekri HS. Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis. J Res Pharm Pract. 2015 Apr-Jun;4(2):51-6. doi: 10.4103/2279-042X.155750. PMID: 25984541; PMCID: PMC4418136.
Copy Download .nbib Format: NLM
Cost effectiveness of type 2 diabetes screening: A systematic review.

Medical journal of the Islamic Republic of Iran

Najafi B, Farzadfar F, Ghaderi H, Hadian M.
PMID: 27390696
Med J Islam Repub Iran. 2016 Feb 13;30:326. eCollection 2016.

BACKGROUND: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.METHODS: We reviewed the MEDLINE, Scopus, Web...

Cite
Najafi B, Farzadfar F, Ghaderi H, et al. Cost effectiveness of type 2 diabetes screening: A systematic review. Med J Islam Repub Iran. 2016;30:326
Najafi, B., Farzadfar, F., Ghaderi, H., & Hadian, M. (2016). Cost effectiveness of type 2 diabetes screening: A systematic review. Medical journal of the Islamic Republic of Iran, 30326.
Najafi, Behzad, et al. "Cost effectiveness of type 2 diabetes screening: A systematic review." Medical journal of the Islamic Republic of Iran vol. 30 (2016): 326.
Najafi B, Farzadfar F, Ghaderi H, Hadian M. Cost effectiveness of type 2 diabetes screening: A systematic review. Med J Islam Repub Iran. 2016 Feb 13;30:326. eCollection 2016. PMID: 27390696; PMCID: PMC4898846.
Copy Download .nbib Format: NLM
Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models.

Journal of diabetes and metabolic disorders

Shams-Beyranvand M, Farzadfar F, Naderimagham S, Tirani M, Maracy MR.
PMID: 28331842
J Diabetes Metab Disord. 2017 Mar 15;16:12. doi: 10.1186/s40200-017-0294-6. eCollection 2017.

BACKGROUND: Over the past decade, cardiovascular diseases (CVDs) have been the leading cause of death in the world. Ischemic heart diseases (IHDs) are the main form of CVDs and are the most important single cause of death around the...

Cite
Shams-Beyranvand M, Farzadfar F, Naderimagham S, et al. Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models. J Diabetes Metab Disord. 2017;16:12doi: 10.1186/s40200-017-0294-6.
Shams-Beyranvand, M., Farzadfar, F., Naderimagham, S., Tirani, M., & Maracy, M. R. (2017). Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models. Journal of diabetes and metabolic disorders, 1612. https://doi.org/10.1186/s40200-017-0294-6
Shams-Beyranvand, Mehran, et al. "Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models." Journal of diabetes and metabolic disorders vol. 16 (2017): 12. doi: https://doi.org/10.1186/s40200-017-0294-6
Shams-Beyranvand M, Farzadfar F, Naderimagham S, Tirani M, Maracy MR. Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models. J Diabetes Metab Disord. 2017 Mar 15;16:12. doi: 10.1186/s40200-017-0294-6. eCollection 2017. PMID: 28331842; PMCID: PMC5353952.
Copy Download .nbib Format: NLM
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment.

Population health metrics

Farzadfar F, Danaei G, Namdaritabar H, Rajaratnam JK, Marcus JR, Khosravi A, Alikhani S, Murray CJ, Ezzati M.
PMID: 21989074
Popul Health Metr. 2011 Oct 11;9(1):55. doi: 10.1186/1478-7954-9-55.

BACKGROUND: Mortality from cardiovascular and other chronic diseases has increased in Iran. Our aim was to estimate the effects of smoking and high systolic blood pressure (SBP), fasting plasma glucose (FPG), total cholesterol (TC), and high body mass index...

Cite
Farzadfar F, Danaei G, Namdaritabar H, et al. National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr. 2011;9(1):55doi: 10.1186/1478-7954-9-55.
Farzadfar, F., Danaei, G., Namdaritabar, H., Rajaratnam, J. K., Marcus, J. R., Khosravi, A., Alikhani, S., Murray, C. J., & Ezzati, M. (2011). National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Population health metrics, 9(1), 55. https://doi.org/10.1186/1478-7954-9-55
Farzadfar, Farshad, et al. "National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment." Population health metrics vol. 9,1 (2011): 55. doi: https://doi.org/10.1186/1478-7954-9-55
Farzadfar F, Danaei G, Namdaritabar H, Rajaratnam JK, Marcus JR, Khosravi A, Alikhani S, Murray CJ, Ezzati M. National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr. 2011 Oct 11;9(1):55. doi: 10.1186/1478-7954-9-55. PMID: 21989074; PMCID: PMC3229448.
Copy Download .nbib Format: NLM
A seroprevalence and relationship survey of brucellosis between pregnant women and women with spontaneous abortion in Iran.

Medical journal of the Islamic Republic of Iran

Ahmadi A, Mohsenpour B, Doroudian P, Mokarizadeh A, Roshani D, Shahgheibi S, Zandvakili F, Farhadifar F, Seyedoshohadaei F.
PMID: 29445671
Med J Islam Repub Iran. 2017 Aug 01;31:42. doi: 10.14196/mjiri.31.42. eCollection 2017.

No abstract available.

Cite
Ahmadi A, Mohsenpour B, Doroudian P, et al. A seroprevalence and relationship survey of brucellosis between pregnant women and women with spontaneous abortion in Iran. Med J Islam Repub Iran. 2017;31:42doi: 10.14196/mjiri.31.42.
Ahmadi, A., Mohsenpour, B., Doroudian, P., Mokarizadeh, A., Roshani, D., Shahgheibi, S., Zandvakili, F., Farhadifar, F., & Seyedoshohadaei, F. (2017). A seroprevalence and relationship survey of brucellosis between pregnant women and women with spontaneous abortion in Iran. Medical journal of the Islamic Republic of Iran, 3142. https://doi.org/10.14196/mjiri.31.42
Ahmadi, Amjad, et al. "A seroprevalence and relationship survey of brucellosis between pregnant women and women with spontaneous abortion in Iran." Medical journal of the Islamic Republic of Iran vol. 31 (2017): 42. doi: https://doi.org/10.14196/mjiri.31.42
Ahmadi A, Mohsenpour B, Doroudian P, Mokarizadeh A, Roshani D, Shahgheibi S, Zandvakili F, Farhadifar F, Seyedoshohadaei F. A seroprevalence and relationship survey of brucellosis between pregnant women and women with spontaneous abortion in Iran. Med J Islam Repub Iran. 2017 Aug 01;31:42. doi: 10.14196/mjiri.31.42. eCollection 2017. PMID: 29445671; PMCID: PMC5804462.
Copy Download .nbib Format: NLM
National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.

Journal of diabetes and metabolic disorders

Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, Sayyari AA, Asadi-Lari M, Delavari A, Farzadfar F, Haghdoost A, Heshmat R, Jamshidi H, Kalantari N, Koosha A, Takian A, Larijani B.
PMID: 28127543
J Diabetes Metab Disord. 2017 Jan 23;16:3. doi: 10.1186/s40200-017-0288-4. eCollection 2017.

Emerging Non-communicable diseases burden move United Nation to call for 25% reduction by 2025 in premature mortality from non-communicable diseases (NCDs). The World Health Organization (WHO) developed global action plan for prevention and control NCDs, but the countries' contexts,...

Cite
Peykari N, Hashemi H, Dinarvand R, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16:3doi: 10.1186/s40200-017-0288-4.
Peykari, N., Hashemi, H., Dinarvand, R., Haji-Aghajani, M., Malekzadeh, R., Sadrolsadat, A., Sayyari, A. A., Asadi-Lari, M., Delavari, A., Farzadfar, F., Haghdoost, A., Heshmat, R., Jamshidi, H., Kalantari, N., Koosha, A., Takian, A., & Larijani, B. (2017). National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. Journal of diabetes and metabolic disorders, 163. https://doi.org/10.1186/s40200-017-0288-4
Peykari, Niloofar, et al. "National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic." Journal of diabetes and metabolic disorders vol. 16 (2017): 3. doi: https://doi.org/10.1186/s40200-017-0288-4
Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, Sayyari AA, Asadi-Lari M, Delavari A, Farzadfar F, Haghdoost A, Heshmat R, Jamshidi H, Kalantari N, Koosha A, Takian A, Larijani B. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017 Jan 23;16:3. doi: 10.1186/s40200-017-0288-4. eCollection 2017. PMID: 28127543; PMCID: PMC5260033.
Copy Download .nbib Format: NLM
Occurrence of Arabis mosaic virus and Grapevine leaf roll associated virus-3 on Grapevines in Iran.

Plant disease

Pourrahim R, Ahoonmanesh A, Farzadfar S, Rakhshandehro F, Golnaraghi AR.
PMID: 30812626
Plant Dis. 2004 Apr;88(4):424. doi: 10.1094/PDIS.2004.88.4.424A.

During 2001, a survey was conducted in vineyards in northwestern Iran and the eastern and western provinces of Azarbaijan, Zanjan, and Qazvin to detect the presence of Arabis mosaic virus (ArMV) and Grapevine leaf roll associated virus-3 (GLRaV-3). From...

Cite
Pourrahim R, Ahoonmanesh A, Farzadfar S, et al. Occurrence of Arabis mosaic virus and Grapevine leaf roll associated virus-3 on Grapevines in Iran. Plant Dis. 2004;88(4):424doi: 10.1094/PDIS.2004.88.4.424A.
Pourrahim, R., Ahoonmanesh, A., Farzadfar, S., Rakhshandehro, F., & Golnaraghi, A. R. (2004). Occurrence of Arabis mosaic virus and Grapevine leaf roll associated virus-3 on Grapevines in Iran. Plant disease, 88(4), 424. https://doi.org/10.1094/PDIS.2004.88.4.424A
Pourrahim, R, et al. "Occurrence of Arabis mosaic virus and Grapevine leaf roll associated virus-3 on Grapevines in Iran." Plant disease vol. 88,4 (2004): 424. doi: https://doi.org/10.1094/PDIS.2004.88.4.424A
Pourrahim R, Ahoonmanesh A, Farzadfar S, Rakhshandehro F, Golnaraghi AR. Occurrence of Arabis mosaic virus and Grapevine leaf roll associated virus-3 on Grapevines in Iran. Plant Dis. 2004 Apr;88(4):424. doi: 10.1094/PDIS.2004.88.4.424A. PMID: 30812626.
Copy Download .nbib Format: NLM
Single-Nucleotide-Resolution Computing and Memory in Living Cells.

Molecular cell

Farzadfard F, Gharaei N, Higashikuni Y, Jung G, Cao J, Lu TK.
PMID: 31442423
Mol Cell. 2019 Aug 22;75(4):769-780.e4. doi: 10.1016/j.molcel.2019.07.011.

The ability to process and store information in living cells is essential for developing next-generation therapeutics and studying biology in situ. However, existing strategies have limited recording capacity and are challenging to scale. To overcome these limitations, we developed...

Cite
Farzadfard F, Gharaei N, Higashikuni Y, et al. Single-Nucleotide-Resolution Computing and Memory in Living Cells. Mol Cell. 2019;75(4):769-780.e4doi: 10.1016/j.molcel.2019.07.011.
Farzadfard, F., Gharaei, N., Higashikuni, Y., Jung, G., Cao, J., & Lu, T. K. (2019). Single-Nucleotide-Resolution Computing and Memory in Living Cells. Molecular cell, 75(4), 769-780.e4. https://doi.org/10.1016/j.molcel.2019.07.011
Farzadfard, Fahim, et al. "Single-Nucleotide-Resolution Computing and Memory in Living Cells." Molecular cell vol. 75,4 (2019): 769-780.e4. doi: https://doi.org/10.1016/j.molcel.2019.07.011
Farzadfard F, Gharaei N, Higashikuni Y, Jung G, Cao J, Lu TK. Single-Nucleotide-Resolution Computing and Memory in Living Cells. Mol Cell. 2019 Aug 22;75(4):769-780.e4. doi: 10.1016/j.molcel.2019.07.011. PMID: 31442423; PMCID: PMC7001763.
Copy Download .nbib Format: NLM
Modification of reduced graphene/Au-aptamer to develop an electrochemical based aptasensor for measurement of glycated albumin.

Talanta

Farzadfard A, Shayeh JS, Habibi-Rezaei M, Omidi M.
PMID: 32070572
Talanta. 2020 May 01;211:120722. doi: 10.1016/j.talanta.2020.120722. Epub 2020 Jan 07.

Herein, an electrochemical label-free biosensor designed for the detection of glycated albumin (GA) using reduced graphene oxide/Au nanoparticles (RGO/AuNPs) modified by anti-GA aptamer. For fast and simple modification of the electrode, the aptamer chain was thiolated. Transition electron microscopy...

Cite
Farzadfard A, Shayeh JS, Habibi-Rezaei M, et al. Modification of reduced graphene/Au-aptamer to develop an electrochemical based aptasensor for measurement of glycated albumin. Talanta. 2020;211:120722doi: 10.1016/j.talanta.2020.120722.
Farzadfard, A., Shayeh, J. S., Habibi-Rezaei, M., & Omidi, M. (2020). Modification of reduced graphene/Au-aptamer to develop an electrochemical based aptasensor for measurement of glycated albumin. Talanta, 211120722. https://doi.org/10.1016/j.talanta.2020.120722
Farzadfard, Azad, et al. "Modification of reduced graphene/Au-aptamer to develop an electrochemical based aptasensor for measurement of glycated albumin." Talanta vol. 211 (2020): 120722. doi: https://doi.org/10.1016/j.talanta.2020.120722
Farzadfard A, Shayeh JS, Habibi-Rezaei M, Omidi M. Modification of reduced graphene/Au-aptamer to develop an electrochemical based aptasensor for measurement of glycated albumin. Talanta. 2020 May 01;211:120722. doi: 10.1016/j.talanta.2020.120722. Epub 2020 Jan 07. PMID: 32070572.
Copy Download .nbib Format: NLM
Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients.

Journal of blood medicine

Farzadfard E, Kalantari T, Tamaddon G.
PMID: 32210655
J Blood Med. 2020 Mar 12;11:97-102. doi: 10.2147/JBM.S230842. eCollection 2020.

PURPOSE: MicroRNAs are small single-strand noncoding RNAs that can be deregulated in a variety of cancers. Over the past few years, multiple markers have been discovered in chronic lymphocytic leukemia (CLL). Among these, miRNAs seem to have important roles...

Cite
Farzadfard E, Kalantari T, Tamaddon G. Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients. J Blood Med. 2020;11:97-102doi: 10.2147/JBM.S230842.
Farzadfard, E., Kalantari, T., & Tamaddon, G. (2020). Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients. Journal of blood medicine, 1197-102. https://doi.org/10.2147/JBM.S230842
Farzadfard, Ehsan, et al. "Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients." Journal of blood medicine vol. 11 (2020): 97-102. doi: https://doi.org/10.2147/JBM.S230842
Farzadfard E, Kalantari T, Tamaddon G. Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients. J Blood Med. 2020 Mar 12;11:97-102. doi: 10.2147/JBM.S230842. eCollection 2020. PMID: 32210655; PMCID: PMC7075349.
Copy Download .nbib Format: NLM
Efficient retroelement-mediated DNA writing in bacteria.

Cell systems

Farzadfard F, Gharaei N, Citorik RJ, Lu TK.
PMID: 34358440
Cell Syst. 2021 Sep 22;12(9):860-872.e5. doi: 10.1016/j.cels.2021.07.001. Epub 2021 Aug 05.

The ability to efficiently and dynamically change information stored in genomes would enable powerful strategies for studying cell biology and controlling cellular phenotypes. Current recombineering-mediated DNA writing platforms in bacteria are limited to specific laboratory conditions, often suffer from...

Cite
Farzadfard F, Gharaei N, Citorik RJ, et al. Efficient retroelement-mediated DNA writing in bacteria. Cell Syst. 2021;12(9):860-872.e5doi: 10.1016/j.cels.2021.07.001.
Farzadfard, F., Gharaei, N., Citorik, R. J., & Lu, T. K. (2021). Efficient retroelement-mediated DNA writing in bacteria. Cell systems, 12(9), 860-872.e5. https://doi.org/10.1016/j.cels.2021.07.001
Farzadfard, Fahim, et al. "Efficient retroelement-mediated DNA writing in bacteria." Cell systems vol. 12,9 (2021): 860-872.e5. doi: https://doi.org/10.1016/j.cels.2021.07.001
Farzadfard F, Gharaei N, Citorik RJ, Lu TK. Efficient retroelement-mediated DNA writing in bacteria. Cell Syst. 2021 Sep 22;12(9):860-872.e5. doi: 10.1016/j.cels.2021.07.001. Epub 2021 Aug 05. PMID: 34358440.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 161 entries